| Literature DB >> 32093337 |
Rodrigo M Carrillo-Larco1,2,3, Antonio Bernabe-Ortiz2,4.
Abstract
Sodium/salt consumption is a risk factor for cardiovascular diseases. Although global targets to reduce salt intake have been established, current levels and trends of sodium consumption in Latin America and the Caribbean (LAC) are unknown. We conducted a systematic review and meta-analysis of population-based studies in which sodium consumption was analyzed based on urine samples (24 hour samples or otherwise). The search was conducted in Medline, Embase, Global Health, Scopus and LILACS. From 2350 results, 53 were studied in detail, of which 15 reports were included, providing evidence for 18 studies. Most studies were from Brazil (7/18) and six collected 24 hour urine samples. In the random effects meta-analysis, 12 studies (29,875 people) were analyzed since 2010. The pooled mean 24 hour estimated sodium consumption was 4.13 g/day (10.49 g/day of salt). When only national surveys were analyzed, the pooled mean was 3.43 g/day (8.71 g/day of salt); when only community studies were analyzed the pooled mean was 4.39 g/day (11.15 g/day of salt). Studies had low risk of bias. The estimated 24 hour sodium consumption is more than twice the World Health Organization recommendations since 2010. Regional organizations and governments should strengthen policies and interventions to measure and reduce sodium consumption in LAC.Entities:
Keywords: dietary; global health; sodium; sodium chloride
Mesh:
Substances:
Year: 2020 PMID: 32093337 PMCID: PMC7071427 DOI: 10.3390/nu12020556
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Study characteristics.
| Author | Country | Type | Sample | Mean Age (Years) | Proportion Men (%) | Proportion | Sodium Assessment | Collection Time |
|---|---|---|---|---|---|---|---|---|
| Carbajal, 2001 [ | ARG | Community | 1225 | 37.06 | 35.83 | Results were multiplied by 3 (i.e., 24 h) | Overnight (from 23 h to 7 h) | |
| Lamelas, 2016 [ | ARG | Community | 6529 | 51.10 | 39.00 | 51.60 | Kawasaki formula was used to estimate 24 h sodium excretion, surrogate of daily sodium consumption | Morning fasting midstream urine sample |
| Lamelas, 2016 [ | BRA | Community | 5323 | 52.20 | 45.20 | 52.50 | Kawasaki formula was used to estimate 24 h sodium excretion, surrogate of daily sodium consumption | Morning fasting midstream urine sample |
| Lamelas, 2016 [ | CHL | Community | 668 | 52.00 | 33.70 | 41.30 | Kawasaki formula was used to estimate 24 h sodium excretion, surrogate of daily sodium consumption | Morning fasting midstream urine sample |
| Lamelas, 2016 [ | COL | Community | 4513 | 50.80 | 37.10 | 37.70 | Kawasaki formula was used to estimate 24 h sodium excretion, surrogate of daily sodium consumption | Morning fasting midstream urine sample |
| Moliterno 2018 [ | URY | Community | 149 | 52.69 | 40.30 | 36.23 | As per urine samples | Participants were instructed to collect a 24 h urine sample |
| Del Pozo, 1990 [ | ECU | Community | 332 | 47.59 | ~110/75 | |||
| Perin, 2018 [ | BRA | Community | 517 | 53.50 | 41.60 | 44.50 | As per urine samples | Participants were instructed to collect a 24 h urine sample |
| Mill, 2019 [ | BRA | National | 8083 | Tanaka formula was used to estimate the 24 h sodium excretion | Random sample (as long as the participant had gone at least 2 h without urinating | |||
| Lopez-Rodrigez, 2009 [ | CHL | Community | 48 | 39.00 | 121.5/79.5 | Tanaka formula was used to estimate the 24 h sodium excretion | Random sample | |
| Bisi, 2003 [ | BRA | Community | 1663 | 44.97 | 45.90 | 42.69 | As per urine samples (here multiplied by 2) | 12 h urine collection |
| Cipullo, 2010 [ | BRA | Community | 1717 | 55.00 | 48.80 | 44.38 | As per urine samples | 12 h urine collection |
| Rodrigues, 2015 [ | BRA | Community | 272 | 44.00 | 47.43 | 31.25 | As per urine samples | Participants were instructed to collect a 24 h urine sample |
| Costa, 1990 [ | BRA | Community | 4565 | 11.75 | Grams of NaCl per day were estimated by the antilogarithm of the average log(Na/creatinine) of spot urine samples times 1.60 (adjustment for daily creatinine) times 0.058 | Random sample | ||
| Petermann-Rocha, 2019 [ | CHL | National | 2913 | 46.47 | 41.74 | 128.4/76.5 | Tanaka formula was used to estimate the 24 h sodium excretion | Random sample |
| Carrillo-Larco, 2018 [ | PER | Community | 409 | 45.70 | 44.00 | 17.00 | As per urine samples | Participants were instructed to collect a 24 h urine sample |
| Harris, 2018 [ | BRB | National | 364 | 44.23 | 34.10 | As per urine samples | Participants were instructed to collect a 24 h urine sample | |
| Campino, 2016 [ | CHL | Community | 135 | 41.2 | 48.15 | As per urine samples | Participants were instructed to collect a 24 h urine sample |
HTN: hypertension. *In three cases mean systolic/diastolic blood pressure were only reported.
Sodium consumption.
| Author | Country | Sodium (g/Day) | Salt (g/Day) |
|---|---|---|---|
| Carbajal, 2001 [ | ARG | 3.02 | 7.68 |
| Lamelas, 2016 [ | ARG | 4.66 | 11.84 |
| Lamelas, 2016 [ | BRA | 4.57 | 11.61 |
| Lamelas, 2016 [ | CHL | 4.88 | 12.40 |
| Lamelas, 2016 [ | COL | 4.89 | 12.42 |
| Moliterno 2018 [ | URY | 3.52 | 8.93 |
| Del Pozo, 1990 [ | ECU | 4.63 | 11.75 |
| Perin, 2018 [ | BRA | 4.13 | 10.50 |
| Mill, 2019 [ | BRA | 3.68 | 9.34 |
| Lopez-Rodrigez, 2009 [ | CHL | 4.10 | 10.41 |
| Bisi, 2003 [ | BRA | 4.55 | 11.57 |
| Cipullo, 2010 [ | BRA | Urinary sodium in normotensive: <100 mEq/L = 55.1%; 100–149 mEq/L = 25.8%; ≥150 mEq/L = 19.1%. Urinary sodium in hypertensive: <100 mEq/L = 43.5%; 100–149 mEq/L = 29.8%; ≥150 mEq/L = 26.7%. | |
| Rodrigues, 2015 [ | BRA | 4.06 | 10.31 |
| Costa, 1990 [ | BRA | 5.09 | 12.93 |
| Petermann-Rocha, 2019 [ | CHL | 3.88 | 9.86 |
| Carrillo-Larco, 2018 [ | PER | 4.40 | 11.18 |
| Harris, 2018 [ | BRB | 2.66 | 6.76 |
| Campino, 2016 [ | CHL | 4.16 | 10.57 |
Salt was estimated as sodium times 2.54.
Figure 1Study selection.
Meta-regression analysis.
| Coef | 95% confidence interval ( | |
|---|---|---|
| Sodium analysis (ref: as per urine samples) | ||
| Formula-based | 0.60 | −0.14; 1.36 (0.102) |
| Survey scope (ref: national) | ||
| Community |
|
|
| Urine collection (ref: 24 h) | ||
| Different than 24 h | 0.61 | −0.14; 1.36 (0.102) |
| Proportion of men (continuous) | −0.06 | −0.17; 0.04 (0.196) |
| Mean age (continuous) | 0.03 | −0.06; 0.11 (0.519) |
| Proportion of hypertension (continuous) | 0.02 | −0.04; 0.08 (0.476) |
| Publication year (continuous) |
|
|
Estimates in bold are those with p < 0.05.
Risk of bias.
| Author | Country | Representativeness | Selection | Ascertainment | Assessment |
|---|---|---|---|---|---|
| Carbajal, 2001 [ | ARG | ||||
| Lamelas, 2016 [ | ARG | ||||
| Lamelas, 2016 [ | BRA | ||||
| Lamelas, 2016 [ | CHL | ||||
| Lamelas, 2016 [ | COL | ||||
| Moliterno 2018 [ | URY | ||||
| Del Pozo, 1990 [ | ECU | ||||
| Perin, 2018 [ | BRA | ||||
| Mill, 2019 [ | BRA | ||||
| Lopez-Rodrigez, 2009 [ | CHL | ||||
| Bisi, 2003 [ | BRA | ||||
| Cipullo, 2010 [ | BRA | ||||
| Rodrigues, 2015 [ | BRA | ||||
| Costa, 1990 [ | BRA | ||||
| Petermann-Rocha, 2019 [ | CHL | ||||
| Carrillo-Larco, 2018 [ | PER | ||||
| Harris, 2018 [ | BRB | ||||
| Campino, 2016 [ | CHL |
The more there are, the lower the risk of bias.